NO772960L - Fremgangsmaate til fremstilling av cefalosporinderivater - Google Patents

Fremgangsmaate til fremstilling av cefalosporinderivater

Info

Publication number
NO772960L
NO772960L NO772960A NO772960A NO772960L NO 772960 L NO772960 L NO 772960L NO 772960 A NO772960 A NO 772960A NO 772960 A NO772960 A NO 772960A NO 772960 L NO772960 L NO 772960L
Authority
NO
Norway
Prior art keywords
procedure
preparation
cephalosporine derivatives
cephalosporine
derivatives
Prior art date
Application number
NO772960A
Other languages
English (en)
Other versions
NO154015C (no
NO154015B (no
Inventor
Kenzo Naito
Kazuo Tsukamura
Haruo Sinbo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO772960L publication Critical patent/NO772960L/no
Publication of NO154015B publication Critical patent/NO154015B/no
Publication of NO154015C publication Critical patent/NO154015C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO772960A 1976-08-31 1977-08-26 Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat. NO154015C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51104583A JPS603314B2 (ja) 1976-08-31 1976-08-31 セフアロスポリン誘導体およびその製造法

Publications (3)

Publication Number Publication Date
NO772960L true NO772960L (no) 1978-03-01
NO154015B NO154015B (no) 1986-03-24
NO154015C NO154015C (no) 1986-07-02

Family

ID=14384446

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772960A NO154015C (no) 1976-08-31 1977-08-26 Analogifremgangsmaate for fremstilling av et krystallinsk, antibiotisk virksomt cefalosporinderivat.

Country Status (15)

Country Link
US (1) US4146710A (no)
JP (1) JPS603314B2 (no)
BE (1) BE858296A (no)
BG (1) BG60439B2 (no)
CA (1) CA1102310A (no)
CH (1) CH630088A5 (no)
DE (1) DE2738711C2 (no)
DK (1) DK151340C (no)
FR (1) FR2364922A1 (no)
GB (1) GB1589841A (no)
HK (1) HK27784A (no)
MY (1) MY8500266A (no)
NL (1) NL189355C (no)
NO (1) NO154015C (no)
SE (1) SE426069B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4189479A (en) * 1977-12-22 1980-02-19 Takeda Chemical Industries, Ltd. Cephalosporin esters
US4180658A (en) * 1978-02-24 1979-12-25 Bristol-Myers Company 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
JPS5579393A (en) * 1978-12-11 1980-06-14 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
JPS58189186A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd セフアロスポリン誘導体
JPS63266177A (ja) * 1987-04-22 1988-11-02 Toyota Autom Loom Works Ltd 揺動斜板型圧縮機におけるコンロツドの連結方法
JPH06122630A (ja) * 1992-10-12 1994-05-06 Taiyo Yakuhin Kogyo Kk 安定な塩酸セフォチアム製剤
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
CN104926835B (zh) * 2015-06-24 2017-10-03 山东罗欣药业集团股份有限公司 一种盐酸头孢替安化合物、其制备方法及其药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho

Also Published As

Publication number Publication date
DK151340C (da) 1988-04-25
CH630088A5 (de) 1982-05-28
HK27784A (en) 1984-03-30
GB1589841A (en) 1981-05-20
MY8500266A (en) 1985-12-31
FR2364922A1 (fr) 1978-04-14
BE858296A (fr) 1978-02-28
DK151340B (da) 1987-11-23
JPS5329913A (en) 1978-03-20
SE426069B (sv) 1982-12-06
JPS603314B2 (ja) 1985-01-26
NL189355C (nl) 1993-03-16
DE2738711A1 (de) 1978-03-02
DK385777A (da) 1978-03-01
SE7709745L (sv) 1978-03-01
CA1102310A (en) 1981-06-02
NL7709614A (nl) 1978-03-02
US4146710A (en) 1979-03-27
NO154015C (no) 1986-07-02
BG60439B2 (bg) 1995-03-31
NO154015B (no) 1986-03-24
DE2738711C2 (de) 1985-07-11
FR2364922B1 (no) 1981-07-31
NL189355B (nl) 1992-10-16

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE433081B (sv) Forfarande for framstellning av cefalosporinforeningar
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707407L (sv) Forfarande for framstellning av cefamderivat
DK528777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO771263L (no) Fremgangsm}te for fremstilling av indol-naftyridin-derivater
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
NO793103L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE436744B (sv) Forfarande for framstellning av prostacyklinderivat
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE433354B (sv) Forfarande for framstellning av cefalosporinderivat